No abstract

No abstract

Obsessive-compulsive disorder (OCD) is a persistent psychiatric disorder causing significant impairment in functioning. The COVID-19 pandemic has exacerbated OCD-related symptoms and interrupted access to treatment. Recent research suggests mHealth apps are promising tools for coping with OCD symptoms. This randomized controlled trial evaluated the effects of a CBT-based mobile application designed to reduce OCD symptoms and cognitions in community participants considered at high-risk of developing OCD symptoms. Following initial screening ( n =924), fifty-five community participants scoring 2 standard deviations above the OCI-R mean were randomized into two groups. In the immediate-app use group (iApp; n =25), participants started using the application at baseline (T0), 4min a day, for 12 days (T0 - T1). Participants in the delayed-app group (dApp; n =20) started using the mobile application at T1 (crossover) and used the app for the following 12 consecutive days (T1 - T2). Intention to treat analyses indicated that using the app for 12 consecutive days was associated with large effect-size reductions (Cohen’s d ranging from .87 to 2.73) in OCD symptoms and maladaptive cognitions in the iApp group (from T0 to T1) and dApp group (from T1 to T2). These reductions were maintained at follow-up. Our findings underscore the usefulness of brief, low-intensity, portable interventions in reducing OCD symptoms and cognitions during the pandemic.

The COVID-19 pandemic has significantly affected the mental health of the general population worldwide. The study aimed to determine the associations of the intolerance of uncertainty (IU) and cognitive flexibility (CF) with a variety of psychological symptoms and to examine the impact of IU on psychological symptoms through the moderating role of CF. The Brief Symptom Inventory, Intolerance of Uncertainty Scale-12, and Cognitive Control and Flexibility Questionnaire were applied to a sample of 3004 adults living in Turkey. The results of the analysis indicated that CF moderated the effect of IU on psychology symptoms. The slope analysis revealed a weakening association between IU and psychological symptoms with the introduction of a high CF level introduced to the model. The findings highlighted the importance of IU as a potential risk factor for developing psychological symptoms while CF appears as a potential protective factor during the COVID-19 pandemic.

No abstract